openPR Logo
Press release

Wearable Injector Market - Global Industry Analysis 2025

10-30-2017 09:20 AM CET | Health & Medicine

Press release from: Wearable Injector Market

Wearable Injector Market - Global Industry Analysis 2025

Drugs are mostly viscous and has various formulations (intravenous, intramuscular, and subcutaneous) that needs to be absorbed into digestive tract, which raise multiple drug delivery issue with traditional drug delivery system. Moreover, such issues not only raise costs but also decrease satisfaction and compliance of patients. Wearable injectors or bolus injectors are the new class for drug delivery device designed for subcutaneous delivery. It has capacity to hold the drug volume of up to 2.5 ml. Wearable injectors are easy to handle, low cost, disposable, and allow self-administration. Advancement in injector technology over traditional drug delivery system include single button to release the drug and after completion of drug in body, the needle is retracted and gets locked automatically. Thus, it’s safe and convenient disposable system benefits people who has needle phobia. Furthermore, it allows audible and visual signals, which is expected to fuel the growth of wearable injector market during forecast period.

Request to download and view Sample Report:

Wearable Injector Market Taxonomy:

By Product type

On-body (Adhesive patch)
Off-body (Belt clip)

By Usage


By Technology

Rotary Pump
Expanding battery
Pressurized Gas
Collapsible Reservoir

By Application

Autoimmune diseases
Infectious Diseases

By End-use Industry

Ambulatory Service

Strategies to improve drug delivery system through the introduction of new wearable injectors is expected to propel the growth of wearable injector market

In 2015, Unilife Corporation introduced Imperium, which is an instant patch pump used for insulin. Imperium is a subcutaneous insulin infusion, disposable, prefilled, and multi-day wearable insulin pump. It has various features that include data connectivity for app to constantly remind and update wireless connectivity such as Bluetooth LE. It also provide real-time access to healthcare provider to track the insulin therapy of each patient.

In 2014, Enable Injections LLC has signed an agreement with CSL Behring to develop novel drug delivery devices. Enable Injectors intent to improve comfort, convenience, and compliance administrative device for the patients with rare diseases.

Browse Research Report At:

Enable Injection LLC and Flex entered in agreement to develop and manufacture wearable medical device in 2016. Enable and Flex aims to develop subcutaneous pain-free injection technology with features such as Bluetooth connectivity, monitoring system with smartphone app, mix automation, and passive warming system.

Unilife Corporation entered in an agreement with Amgen to develop customized wearable injectors in 2016. Unilife has granted exclusive rights to Amgen for Unilife’s wearable injectors, with only selected drug classes are used for wearable injector device. Furthermore, Unilife also granted some non-exclusive rights to Amgen for its delivery system of certain therapeutic area that include inflammation, nephrology, oncology, bone health, neuroscience, and cardiovascular.

Increasing prevalence of chronic diseases and high demand for advanced drug delivery device for frequent administration of drug is expected to augment the market growth

According to the World Health Organization (WHO), around 1.6 million deaths caused by diabetes in 2015 and is expected to increase by more than 50% before the age of 70 years by 2030. Moreover, According to National Institute of Health (NIH), in 2017, around 23.5 million people are suffering from autoimmune diseases in U.S.

According to World Health Organization (WHO), in 2017, nearly 1 in every 6 death occurs due to cancer globally and approximately 70% of deaths from cancer occur in low and middle-income countries. Increasing prevalence of chronic disease and high demand for advanced drug delivery devices for frequent administration of drugs is expected to fuel the growth of wearable injector market during the forecast period.

Some of the key players operating in the global wearable injector market include Medtronic Plc, West Pharmaceutical Services, Inc., Enable Injections, F. Hoffmann-La Roche Ltd, scPharmaceuticals, Inc, Johnson & Johnson, Insulet Corporation, Sensile Medical Ag, Becton, and Dickinson And Company.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
Seattle, WA 98154
Tel: +1-206-701-6702
Visit Coherent Market Insights Blog @
Connect with us on LinkedIn @

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Wearable Injector Market - Global Industry Analysis 2025 here

News-ID: 792267 • Views: 397

More Releases for Unilife

Global Parenteral Packaging Market SWOT Analysis, Key Indicators, Forecast 2027 …
Parenteral Packaging The business report released by Zion Market Research on Parenteral Packaging Market: Global Industry Analysis, Size, Share, Growth, Trends, And Forecast, 2020-2026 market is focused to facilitate a deep understanding of the market definition, potential, and scope. The report is curated after deep research and analysis by experts. It consists of an organized and methodical explanation of current market trends to assist the users to entail in-depth market analysis.
Smart Syringes Market Worth Observing Growth | Baxter, Smiths, Unilife
A new research document is added in HTF MI database of 108 pages, titled as 'Global Smart Syringes Market Insights 2019 by Top Regions, Top Manufacturers, Type and Application' with detailed analysis, Competitive landscape, forecast and strategies. Latest analysis highlights high growth emerging players and leaders by market share that are currently attracting exceptional attention. The identification of hot and emerging players is completed by profiling 50+ Industry
Needlestick Safety Injection Devices Market: Top Players - Terumo, Unilife, Cata …
MarketResearchReports.Biz adds “Global Needlestick Safety Injection Devices Market Share, Size, Trends and Forecast Market Research Report” reports to its database. This report provides a strategic analysis of the Needlestick Safety Injection Devices and the growth estimates for the forecasted period. This report studies the Needlestick Safety Injection Devices market status and outlook of global and United States, from angles of players, regions, product types and end industries; this report analyzes the
Global Dual Chamber Syringes Market 2018 - Unilife, SHL Medical, Lyogo
Global Dual Chamber Syringes Market 2018 Analysis Report audits a Market Regions, Product Categories, with Sales, Business Revenue, Goods cost, Dual Chamber Syringes piece of the overall industry and Growth patterns, concentrating on driving Dual Chamber Syringes industry players, showcase size, request and supply examination, utilization volume, Forecast 2017 to 2025. The major regions present in the continents like United States, Germany, Japan and China and their contribution to global Dual
Bolus Injectors Market 2017-Roche, BD Medical, Ratio Inc, Unilife Corporation
Apex Market Reports, recently published a detailed market research study focused on the "Bolus Injectors Market" across the global, regional and country level. The report provides 360° analysis of "Bolus Injectors Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Bolus Injectors industry, and estimates the future trend of Bolus Injectors market